Phibro Animal Health (PAHC) Expected to Announce Quarterly Earnings on Wednesday

Phibro Animal Health (NASDAQ:PAHC) is expected to be announcing its Q3 2025 earnings results after the market closes on Wednesday, May 7th. Analysts expect the company to announce earnings of $0.53 per share and revenue of $352.41 million for the quarter. Phibro Animal Health has set its FY 2025 guidance at 1.870-2.010 EPS.

Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share for the quarter, topping analysts’ consensus estimates of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. On average, analysts expect Phibro Animal Health to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Phibro Animal Health Stock Up 4.7 %

NASDAQ:PAHC opened at $19.48 on Monday. The company has a debt-to-equity ratio of 2.99, a quick ratio of 1.37 and a current ratio of 3.20. The company has a market capitalization of $789.00 million, a price-to-earnings ratio of 40.58, a price-to-earnings-growth ratio of 0.45 and a beta of 0.62. Phibro Animal Health has a one year low of $16.06 and a one year high of $26.55. The stock has a 50-day simple moving average of $20.26 and a 200 day simple moving average of $21.95.

Phibro Animal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Wednesday, March 5th were paid a dividend of $0.12 per share. The ex-dividend date of this dividend was Wednesday, March 5th. This represents a $0.48 dividend on an annualized basis and a yield of 2.46%. Phibro Animal Health’s payout ratio is currently 100.00%.

Wall Street Analysts Forecast Growth

PAHC has been the subject of a number of recent analyst reports. Morgan Stanley set a $20.00 price objective on Phibro Animal Health in a report on Tuesday, April 15th. StockNews.com cut Phibro Animal Health from a “buy” rating to a “hold” rating in a research report on Tuesday, March 25th. Finally, Barclays boosted their target price on shares of Phibro Animal Health from $20.00 to $22.00 and gave the stock an “underweight” rating in a report on Monday, February 10th. Two equities research analysts have rated the stock with a sell rating and three have given a hold rating to the company’s stock. According to MarketBeat.com, Phibro Animal Health has a consensus rating of “Hold” and an average target price of $19.75.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.